Applications Published 18 July 2001
Published: 30-Apr-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Sulfonamide derivatives
Eli Lilly 1115393*Pharmaceutical compsns comprising derivatives of sulphur acids
Pycogen 1115394*Active enantiomer of rargamma-specific agonist
Bristol-Myers Squibb 1115395*Pharmaceutically active compounds and methods of use thereof
Sunol Molecular Corp 1116396*Method of mitigating the adverse effects of interleukin-2
Biomedicines 1115397*Tocopherols, tocotrienols, other chroman and side chain derivativesz and uses thereof
Research Development Foundation 1115398*Use of a pharmaceutical compsn containing, in combination, an agonist of the angiotensin II at 1? receptors and indomethacin for making a medicine treating chronic glomerulonephritis
Sanofi-Synthelabo 1115399* Benzothiazole dioxetanes
Tropix 1115400*Nocel compounds
AstraZeneca 1115401*Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas
Pfizer 1115402*Optimised use of 6-mercaptopurine drug in the treatment of immune-mediated gastrointestinal disorders
Hospital Sainte-Justine 1115403*Use of prostanoid antagonists for the treatment of primary headache disorders
Pharmagene Laboratories 1115404*Use of certain drugs for treating nerve root injury
A+ Science Invest 1115405*Sustained release, and comfortable ophthalmic compsn and method for ocular therapy
Alcon Laboratory 1115406*Compsn, method and apparatus for inducing controlled cognitive disorder
Fuisz, Richard 1115407*Oxihumic acid and its use in the treatment of various conditions
Enerkom 1115408*Compsn for extending post-meal satiety
Kemin Industries 1115409*Isolation of nutrient-rich carotenoids and their formulations
Cahndra, Jhawar Ramesh; Ajanta Pharma 1115410*Extract of nerium species, pharmaceutical compsn thereof and methods of preparation thereof
Ozelie Pharmaceuticals 1115411*Neuroimmunophilins for selective neuronal radioprotection
Keep, Marcus' Elmer, Eskil 1115412* Robust steady-state target calculation for model-based predictive control
Aspen Technology 1115413*Inhibition of erythrocyte sickling by N-L-alpha-aspartyl-l-phenylalanine 1-methyl ester
Oklahoma Medical Research Centre 1115414*Use of compsn in the treatment of schizophrenia
Lakartjaenster I Vaeatsverige 1115415* Use of substances with oxytocin activity in order to create cell regeneration
EntreTech Medical 1115416*Methods for administration of antibiotics
Cubist Pharmacies 1115417*Aglyco products and methods of use
Bogoch, Samuel Dr 1115418*Carbapenem antibacterial compsns and methods of treatment
Merck 1115419*Treatment of hepatitis B infection with thymosin alp[ha 1 and lamivudine
Sciclone Pharmaceutical 1115420*Use of GLP-1 or analogues in treatment of stroke
Eli Lilly 1115421*Use of non-peptidyl compounds for the treatment of insulin related ailments
Curtin University of Technology 1115422*Methods of downmodulating the immune responses to therapeutic proteins Genetic Institute; American Red
Cross 1115423*Method of diagnosing, monitoring, stages, imaging and treating gynecologic cancers and testicular cancer
Diadexus 1115426*Time-staged utilisation of tunour cells in combination with intact antibodies for immunisation
Lindhofer, Horst 1115427*
